Identification and Strategies to Mitigate High Total Clearance of

Metabolism by Aldehyde Oxidase: Drug Design and Complementary

Metabolism by Aldehyde Oxidase: Drug Design and Complementary

William MCCOULL, AstraZeneca, London, AZ

Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase

Identification and Strategies to Mitigate High Total Clearance of

MerTK in complex with EX172 (PDB entry 7AAZ). The kinase domain N

William MCCOULL, AstraZeneca, London, AZ

William MCCOULL, AstraZeneca, London, AZ

Christina CHAN, Researcher, PhD, AstraZeneca, London

Jon WINTER-HOLT, Senior medicinal chemist

PDF) Predicting when Biliary Excretion of Parent Drug is a Major